Surgery Partners, Inc. (NASDAQ: SGRY) Stock Competitors & Peer Comparison
See SGRY's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SGRY and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SGRY | $15.03 | -1.05% | 2B | 38.54 | $0.39 | N/A |
| HCA | $404.68 | -1.71% | 87.6B | 13.97 | $28.96 | +0.74% |
| THC | $267.90 | +0.32% | 21.6B | 15.54 | $17.24 | N/A |
| FMS | $23.77 | +0.59% | 12.8B | 8.93 | $2.66 | +3.64% |
| EHC | $123.59 | +0.03% | 12.3B | 21.16 | $5.84 | +0.61% |
| BTSGU | $203.17 | +1.04% | 12B | 184.06 | $1.11 | N/A |
| DVA | $180.06 | -0.79% | 11.5B | 14.00 | $12.80 | N/A |
| ENSG | $181.65 | -0.13% | 10.6B | 26.33 | $6.90 | +0.14% |
| UHS | $170.02 | -0.70% | 10.3B | 7.54 | $22.54 | +0.47% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
SGRY vs HCA Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, HCA has a market cap of 87.6B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while HCA trades at $404.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas HCA's P/E ratio is 13.97. In terms of profitability, SGRY's ROE is -0.05%, compared to HCA's ROE of -1.13%. Regarding short-term risk, SGRY is more volatile compared to HCA. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
SGRY vs THC Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, THC has a market cap of 21.6B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while THC trades at $267.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas THC's P/E ratio is 15.54. In terms of profitability, SGRY's ROE is -0.05%, compared to THC's ROE of +0.51%. Regarding short-term risk, SGRY is more volatile compared to THC. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check THC's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
SGRY vs FMS Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, FMS has a market cap of 12.8B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while FMS trades at $23.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas FMS's P/E ratio is 8.93. In terms of profitability, SGRY's ROE is -0.05%, compared to FMS's ROE of +0.07%. Regarding short-term risk, SGRY is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
SGRY vs EHC Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, EHC has a market cap of 12.3B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while EHC trades at $123.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas EHC's P/E ratio is 21.16. In terms of profitability, SGRY's ROE is -0.05%, compared to EHC's ROE of +0.25%. Regarding short-term risk, SGRY is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check EHC's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
SGRY vs BTSGU Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, BTSGU has a market cap of 12B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while BTSGU trades at $203.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas BTSGU's P/E ratio is 184.06. In terms of profitability, SGRY's ROE is -0.05%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, SGRY is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check BTSGU's competition here
DaVita Inc. (NYSE: DVA)
SGRY vs DVA Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, DVA has a market cap of 11.5B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while DVA trades at $180.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas DVA's P/E ratio is 14.00. In terms of profitability, SGRY's ROE is -0.05%, compared to DVA's ROE of -1.24%. Regarding short-term risk, SGRY is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check DVA's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
SGRY vs ENSG Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, ENSG has a market cap of 10.6B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while ENSG trades at $181.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas ENSG's P/E ratio is 26.33. In terms of profitability, SGRY's ROE is -0.05%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, SGRY is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
SGRY vs UHS Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, UHS has a market cap of 10.3B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while UHS trades at $170.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas UHS's P/E ratio is 7.54. In terms of profitability, SGRY's ROE is -0.05%, compared to UHS's ROE of +0.21%. Regarding short-term risk, SGRY is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
SGRY vs OSH Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas OSH's P/E ratio is -17.65. In terms of profitability, SGRY's ROE is -0.05%, compared to OSH's ROE of +4.64%. Regarding short-term risk, SGRY is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
SGRY vs PACS Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, PACS has a market cap of 7B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while PACS trades at $44.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas PACS's P/E ratio is 23.51. In terms of profitability, SGRY's ROE is -0.05%, compared to PACS's ROE of +0.27%. Regarding short-term risk, SGRY is more volatile compared to PACS. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
SGRY vs CHE Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, CHE has a market cap of 7B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while CHE trades at $532.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas CHE's P/E ratio is 24.67. In terms of profitability, SGRY's ROE is -0.05%, compared to CHE's ROE of +0.29%. Regarding short-term risk, SGRY is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check CHE's competition here
LHC Group, Inc. (NASDAQ: LHCG)
SGRY vs LHCG Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas LHCG's P/E ratio is 82.83. In terms of profitability, SGRY's ROE is -0.05%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, SGRY is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
SGRY vs LFST Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, LFST has a market cap of 4.8B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while LFST trades at $12.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas LFST's P/E ratio is 93.55. In terms of profitability, SGRY's ROE is -0.05%, compared to LFST's ROE of +0.03%. Regarding short-term risk, SGRY is less volatile compared to LFST. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
SGRY vs CON Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, CON has a market cap of 4.5B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while CON trades at $35.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas CON's P/E ratio is 24.59. In terms of profitability, SGRY's ROE is -0.05%, compared to CON's ROE of +0.47%. Regarding short-term risk, SGRY is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check CON's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
SGRY vs OPCH Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, OPCH has a market cap of 3.6B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while OPCH trades at $23.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas OPCH's P/E ratio is 13.92. In terms of profitability, SGRY's ROE is -0.05%, compared to OPCH's ROE of +0.16%. Regarding short-term risk, SGRY is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check OPCH's competition here
National HealthCare Corporation (AMEX: NHC)
SGRY vs NHC Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, NHC has a market cap of 3.5B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while NHC trades at $223.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas NHC's P/E ratio is 28.34. In terms of profitability, SGRY's ROE is -0.05%, compared to NHC's ROE of +0.13%. Regarding short-term risk, SGRY is less volatile compared to NHC. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check NHC's competition here
Amedisys, Inc. (NASDAQ: AMED)
SGRY vs AMED Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas AMED's P/E ratio is 39.30. In terms of profitability, SGRY's ROE is -0.05%, compared to AMED's ROE of +0.11%. Regarding short-term risk, SGRY is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check AMED's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
SGRY vs BKD Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, BKD has a market cap of 3B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while BKD trades at $12.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas BKD's P/E ratio is -21.77. In terms of profitability, SGRY's ROE is -0.05%, compared to BKD's ROE of +4.06%. Regarding short-term risk, SGRY is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check BKD's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
SGRY vs ACHC Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, ACHC has a market cap of 2.9B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while ACHC trades at $30.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas ACHC's P/E ratio is 15.49. In terms of profitability, SGRY's ROE is -0.05%, compared to ACHC's ROE of -0.50%. Regarding short-term risk, SGRY is less volatile compared to ACHC. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check ACHC's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
SGRY vs AVAH Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, AVAH has a market cap of 2.7B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while AVAH trades at $12.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas AVAH's P/E ratio is 18.12. In terms of profitability, SGRY's ROE is -0.05%, compared to AVAH's ROE of +1.50%. Regarding short-term risk, SGRY is less volatile compared to AVAH. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check AVAH's competition here
Guardian Pharmacy Services, Inc. (NYSE: GRDN)
SGRY vs GRDN Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, GRDN has a market cap of 2.4B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while GRDN trades at $38.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas GRDN's P/E ratio is 33.72. In terms of profitability, SGRY's ROE is -0.05%, compared to GRDN's ROE of +0.31%. Regarding short-term risk, SGRY is less volatile compared to GRDN. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check GRDN's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
SGRY vs MD Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while MD trades at $26.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas MD's P/E ratio is 11.88. In terms of profitability, SGRY's ROE is -0.05%, compared to MD's ROE of +0.20%. Regarding short-term risk, SGRY is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
SGRY vs ADUS Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, ADUS has a market cap of 2.2B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while ADUS trades at $116.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas ADUS's P/E ratio is 17.37. In terms of profitability, SGRY's ROE is -0.05%, compared to ADUS's ROE of +0.10%. Regarding short-term risk, SGRY is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check ADUS's competition here
Select Medical Holdings Corporation (NYSE: SEM)
SGRY vs SEM Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas SEM's P/E ratio is 15.43. In terms of profitability, SGRY's ROE is -0.05%, compared to SEM's ROE of +0.08%. Regarding short-term risk, SGRY is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
SGRY vs ASTH Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, ASTH has a market cap of 2B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while ASTH trades at $40.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas ASTH's P/E ratio is 39.24. In terms of profitability, SGRY's ROE is -0.05%, compared to ASTH's ROE of +0.05%. Regarding short-term risk, SGRY is less volatile compared to ASTH. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check ASTH's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
SGRY vs SNDA Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, SNDA has a market cap of 1.9B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while SNDA trades at $39.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas SNDA's P/E ratio is -7.25. In terms of profitability, SGRY's ROE is -0.05%, compared to SNDA's ROE of -0.26%. Regarding short-term risk, SGRY is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check SNDA's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
SGRY vs AMEH Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas AMEH's P/E ratio is 39.25. In terms of profitability, SGRY's ROE is -0.05%, compared to AMEH's ROE of +0.05%. Regarding short-term risk, SGRY is less volatile compared to AMEH. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check AMEH's competition here
Agilon Health, Inc. (NYSE: AGL)
SGRY vs AGL Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while AGL trades at $96.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas AGL's P/E ratio is -10.83. In terms of profitability, SGRY's ROE is -0.05%, compared to AGL's ROE of -1.19%. Regarding short-term risk, SGRY is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check AGL's competition here
Ardent Health Inc. (NYSE: ARDT)
SGRY vs ARDT Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, ARDT has a market cap of 1.6B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while ARDT trades at $10.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas ARDT's P/E ratio is 8.81. In terms of profitability, SGRY's ROE is -0.05%, compared to ARDT's ROE of +0.05%. Regarding short-term risk, SGRY is more volatile compared to ARDT. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check ARDT's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
SGRY vs HCSG Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, HCSG has a market cap of 1.5B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while HCSG trades at $21.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas HCSG's P/E ratio is 17.27. In terms of profitability, SGRY's ROE is -0.05%, compared to HCSG's ROE of +0.24%. Regarding short-term risk, SGRY is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check HCSG's competition here
Innovage Holding Corp. (NASDAQ: INNV)
SGRY vs INNV Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, INNV has a market cap of 1.4B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while INNV trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas INNV's P/E ratio is -117.89. In terms of profitability, SGRY's ROE is -0.05%, compared to INNV's ROE of -0.09%. Regarding short-term risk, SGRY is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check INNV's competition here
The Pennant Group, Inc. (NASDAQ: PNTG)
SGRY vs PNTG Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, PNTG has a market cap of 1.4B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while PNTG trades at $39.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas PNTG's P/E ratio is 29.79. In terms of profitability, SGRY's ROE is -0.05%, compared to PNTG's ROE of +0.10%. Regarding short-term risk, SGRY is more volatile compared to PNTG. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check PNTG's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
SGRY vs AMN Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while AMN trades at $34.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas AMN's P/E ratio is 11.44. In terms of profitability, SGRY's ROE is -0.05%, compared to AMN's ROE of +0.15%. Regarding short-term risk, SGRY is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check AMN's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
SGRY vs NUTX Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, NUTX has a market cap of 1.3B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while NUTX trades at $187.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas NUTX's P/E ratio is 14.48. In terms of profitability, SGRY's ROE is -0.05%, compared to NUTX's ROE of +0.52%. Regarding short-term risk, SGRY is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check NUTX's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
SGRY vs USPH Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, USPH has a market cap of 1.2B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while USPH trades at $81.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas USPH's P/E ratio is 31.94. In terms of profitability, SGRY's ROE is -0.05%, compared to USPH's ROE of +0.00%. Regarding short-term risk, SGRY is less volatile compared to USPH. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check USPH's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
SGRY vs BKDT Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas BKDT's P/E ratio is N/A. In terms of profitability, SGRY's ROE is -0.05%, compared to BKDT's ROE of +4.06%. Regarding short-term risk, SGRY is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check BKDT's competition here
Talkspace, Inc. (NASDAQ: TALK)
SGRY vs TALK Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, TALK has a market cap of 879.4M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while TALK trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas TALK's P/E ratio is 774.34. In terms of profitability, SGRY's ROE is -0.05%, compared to TALK's ROE of +0.00%. Regarding short-term risk, SGRY is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check TALK's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
SGRY vs FSHCX Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, FSHCX has a market cap of 877.3M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while FSHCX trades at $116.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas FSHCX's P/E ratio is N/A. In terms of profitability, SGRY's ROE is -0.05%, compared to FSHCX's ROE of N/A. Regarding short-term risk, SGRY is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check FSHCX's competition here
GMR Solutions Inc. (NYSE: GMRS)
SGRY vs GMRS Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, GMRS has a market cap of 718.9M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while GMRS trades at $13.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas GMRS's P/E ratio is 5.92. In terms of profitability, SGRY's ROE is -0.05%, compared to GMRS's ROE of +0.16%. Regarding short-term risk, SGRY is less volatile compared to GMRS. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check GMRS's competition here
Enhabit, Inc. (NYSE: EHAB)
SGRY vs EHAB Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas EHAB's P/E ratio is -197.14. In terms of profitability, SGRY's ROE is -0.05%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, SGRY is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check EHAB's competition here
Starling Oncology, Inc. (NASDAQ: STLN)
SGRY vs STLN Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, STLN has a market cap of 644.9M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while STLN trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas STLN's P/E ratio is N/A. In terms of profitability, SGRY's ROE is -0.05%, compared to STLN's ROE of +2.10%. Regarding short-term risk, SGRY is less volatile compared to STLN. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check STLN's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
SGRY vs TOI Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, TOI has a market cap of 512.9M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while TOI trades at $5.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas TOI's P/E ratio is -14.25. In terms of profitability, SGRY's ROE is -0.05%, compared to TOI's ROE of +2.10%. Regarding short-term risk, SGRY is less volatile compared to TOI. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check TOI's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
SGRY vs SRTA Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, SRTA has a market cap of 510.5M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while SRTA trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas SRTA's P/E ratio is -27.81. In terms of profitability, SGRY's ROE is -0.05%, compared to SRTA's ROE of +0.14%. Regarding short-term risk, SGRY is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check SRTA's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
SGRY vs MCTA Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas MCTA's P/E ratio is 419.36. In terms of profitability, SGRY's ROE is -0.05%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, SGRY is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check MCTA's competition here
Community Health Systems, Inc. (NYSE: CYH)
SGRY vs CYH Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, CYH has a market cap of 419.5M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while CYH trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas CYH's P/E ratio is 4.08. In terms of profitability, SGRY's ROE is -0.05%, compared to CYH's ROE of +0.21%. Regarding short-term risk, SGRY is more volatile compared to CYH. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
SGRY vs AUNA Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, AUNA has a market cap of 388.6M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while AUNA trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas AUNA's P/E ratio is 4.73. In terms of profitability, SGRY's ROE is -0.05%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, SGRY is more volatile compared to AUNA. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check AUNA's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
SGRY vs VMD Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, VMD has a market cap of 350.4M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while VMD trades at $9.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas VMD's P/E ratio is 25.56. In terms of profitability, SGRY's ROE is -0.05%, compared to VMD's ROE of +0.10%. Regarding short-term risk, SGRY is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check VMD's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
SGRY vs AIRS Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, AIRS has a market cap of 242M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while AIRS trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas AIRS's P/E ratio is -114.33. In terms of profitability, SGRY's ROE is -0.05%, compared to AIRS's ROE of -0.13%. Regarding short-term risk, SGRY is less volatile compared to AIRS. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check AIRS's competition here
Capital Senior Living Corporation (NYSE: CSU)
SGRY vs CSU Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas CSU's P/E ratio is 0.67. In terms of profitability, SGRY's ROE is -0.05%, compared to CSU's ROE of -0.33%. Regarding short-term risk, SGRY is less volatile compared to CSU. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
SGRY vs JYNT Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, JYNT has a market cap of 120.5M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while JYNT trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas JYNT's P/E ratio is 84.50. In terms of profitability, SGRY's ROE is -0.05%, compared to JYNT's ROE of +0.22%. Regarding short-term risk, SGRY is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check JYNT's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
SGRY vs PARK Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, PARK has a market cap of 103.9M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while PARK trades at $22.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas PARK's P/E ratio is 31.11. In terms of profitability, SGRY's ROE is -0.05%, compared to PARK's ROE of -0.00%. Regarding short-term risk, SGRY is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check PARK's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
SGRY vs FVE Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas FVE's P/E ratio is -5.64. In terms of profitability, SGRY's ROE is -0.05%, compared to FVE's ROE of -0.15%. Regarding short-term risk, SGRY is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
SGRY vs KDLYW Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas KDLYW's P/E ratio is N/A. In terms of profitability, SGRY's ROE is -0.05%, compared to KDLYW's ROE of -1.05%. Regarding short-term risk, SGRY is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check KDLYW's competition here
biote Corp. (NASDAQ: BTMD)
SGRY vs BTMD Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, BTMD has a market cap of 64.8M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while BTMD trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas BTMD's P/E ratio is 13.36. In terms of profitability, SGRY's ROE is -0.05%, compared to BTMD's ROE of -0.09%. Regarding short-term risk, SGRY is more volatile compared to BTMD. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check BTMD's competition here
DocGo Inc. (NASDAQ: DCGO)
SGRY vs DCGO Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, DCGO has a market cap of 64.5M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while DCGO trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas DCGO's P/E ratio is -0.75. In terms of profitability, SGRY's ROE is -0.05%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, SGRY is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check DCGO's competition here
AlerisLife Inc. (NASDAQ: ALR)
SGRY vs ALR Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas ALR's P/E ratio is -1.11. In terms of profitability, SGRY's ROE is -0.05%, compared to ALR's ROE of -0.15%. Regarding short-term risk, SGRY is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check ALR's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
SGRY vs PIII Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, PIII has a market cap of 35M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while PIII trades at $10.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas PIII's P/E ratio is -0.27. In terms of profitability, SGRY's ROE is -0.05%, compared to PIII's ROE of +1.61%. Regarding short-term risk, SGRY is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check PIII's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
SGRY vs IMAC Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas IMAC's P/E ratio is -2.27. In terms of profitability, SGRY's ROE is -0.05%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, SGRY is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check IMAC's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
SGRY vs CCEL Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, CCEL has a market cap of 32.3M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while CCEL trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas CCEL's P/E ratio is -13.33. In terms of profitability, SGRY's ROE is -0.05%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, SGRY is less volatile compared to CCEL. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check CCEL's competition here
EUDA Health Holdings Limited (NASDAQ: EUDA)
SGRY vs EUDA Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, EUDA has a market cap of 26.4M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while EUDA trades at $14.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas EUDA's P/E ratio is -26.63. In terms of profitability, SGRY's ROE is -0.05%, compared to EUDA's ROE of +1.20%. Regarding short-term risk, SGRY is less volatile compared to EUDA. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check EUDA's competition here
Cano Health, Inc. (NYSE: CANO-WT)
SGRY vs CANO-WT Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, SGRY's ROE is -0.05%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, SGRY is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
SGRY vs AIH Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas AIH's P/E ratio is -2.78. In terms of profitability, SGRY's ROE is -0.05%, compared to AIH's ROE of +1.16%. Regarding short-term risk, SGRY is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
SGRY vs CANO Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas CANO's P/E ratio is -0.01. In terms of profitability, SGRY's ROE is -0.05%, compared to CANO's ROE of -1.49%. Regarding short-term risk, SGRY is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
SGRY vs FPCG Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas FPCG's P/E ratio is 0.09. In terms of profitability, SGRY's ROE is -0.05%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, SGRY is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check FPCG's competition here
American Shared Hospital Services (AMEX: AMS)
SGRY vs AMS Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, AMS has a market cap of 9.9M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while AMS trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas AMS's P/E ratio is -6.74. In terms of profitability, SGRY's ROE is -0.05%, compared to AMS's ROE of -0.07%. Regarding short-term risk, SGRY is less volatile compared to AMS. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check AMS's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
SGRY vs FTRP Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas FTRP's P/E ratio is -1.22. In terms of profitability, SGRY's ROE is -0.05%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, SGRY is less volatile compared to FTRP. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check FTRP's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
SGRY vs BMGL Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, BMGL has a market cap of 8.6M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while BMGL trades at $5.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas BMGL's P/E ratio is -1.04. In terms of profitability, SGRY's ROE is -0.05%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, SGRY is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
SGRY vs XWEL Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, XWEL has a market cap of 7.9M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while XWEL trades at $0.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas XWEL's P/E ratio is -0.18. In terms of profitability, SGRY's ROE is -0.05%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, SGRY is less volatile compared to XWEL. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check XWEL's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
SGRY vs AIDX Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, AIDX has a market cap of 6.7M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while AIDX trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas AIDX's P/E ratio is -1.04. In terms of profitability, SGRY's ROE is -0.05%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, SGRY is less volatile compared to AIDX. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check AIDX's competition here
ModivCare Inc. (NASDAQ: MODV)
SGRY vs MODV Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas MODV's P/E ratio is -0.06. In terms of profitability, SGRY's ROE is -0.05%, compared to MODV's ROE of +1.36%. Regarding short-term risk, SGRY is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
SGRY vs GBNH Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas GBNH's P/E ratio is -0.06. In terms of profitability, SGRY's ROE is -0.05%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, SGRY is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
SGRY vs RHE-PA Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, SGRY's ROE is -0.05%, compared to RHE-PA's ROE of +1.09%. Regarding short-term risk, SGRY is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
SGRY vs RHE Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas RHE's P/E ratio is -1.79. In terms of profitability, SGRY's ROE is -0.05%, compared to RHE's ROE of -1.31%. Regarding short-term risk, SGRY is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check RHE's competition here
Oncology Institute, Inc. Warrant 2021-15.11.26 on Oncology Inst (NASDAQ: STLNW)
SGRY vs STLNW Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, STLNW has a market cap of 5M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while STLNW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas STLNW's P/E ratio is N/A. In terms of profitability, SGRY's ROE is -0.05%, compared to STLNW's ROE of N/A. Regarding short-term risk, SGRY is less volatile compared to STLNW. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check STLNW's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
SGRY vs TOIIW Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, TOIIW has a market cap of 4.7M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas TOIIW's P/E ratio is -0.17. In terms of profitability, SGRY's ROE is -0.05%, compared to TOIIW's ROE of +2.10%. Regarding short-term risk, SGRY is more volatile compared to TOIIW. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check TOIIW's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
SGRY vs IMACW Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas IMACW's P/E ratio is N/A. In terms of profitability, SGRY's ROE is -0.05%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, SGRY is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
SGRY vs NAKAW Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, SGRY's ROE is -0.05%, compared to NAKAW's ROE of -1.05%. Regarding short-term risk, SGRY is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
SGRY vs CCM Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, CCM has a market cap of 690.2K. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while CCM trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas CCM's P/E ratio is -0.32. In terms of profitability, SGRY's ROE is -0.05%, compared to CCM's ROE of +0.06%. Regarding short-term risk, SGRY is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
SGRY vs NIVF Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, NIVF has a market cap of 109.4K. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while NIVF trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas NIVF's P/E ratio is 0.28. In terms of profitability, SGRY's ROE is -0.05%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, SGRY is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check NIVF's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
SGRY vs MNDR Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, MNDR has a market cap of 42.3K. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while MNDR trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas MNDR's P/E ratio is -0.04. In terms of profitability, SGRY's ROE is -0.05%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, SGRY is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
SGRY vs NIVFW Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, NIVFW has a market cap of 39.8K. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, SGRY's ROE is -0.05%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, SGRY is more volatile compared to NIVFW. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check NIVFW's competition here
Talkspace, Inc. (NASDAQ: TALKW)
SGRY vs TALKW Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, TALKW has a market cap of 33.5K. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas TALKW's P/E ratio is 0.00. In terms of profitability, SGRY's ROE is -0.05%, compared to TALKW's ROE of +0.00%. Regarding short-term risk, SGRY is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check TALKW's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
SGRY vs TVTY Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas TVTY's P/E ratio is 19.06. In terms of profitability, SGRY's ROE is -0.05%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, SGRY is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check TVTY's competition here
Kindred Healthcare, Inc. (NYSE: KND)
SGRY vs KND Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, KND has a market cap of 0. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas KND's P/E ratio is -1.14. In terms of profitability, SGRY's ROE is -0.05%, compared to KND's ROE of -0.53%. Regarding short-term risk, SGRY is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check KND's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
SGRY vs ATIP-WT Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, SGRY's ROE is -0.05%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, SGRY is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check ATIP-WT's competition here
Hanger, Inc. (NYSE: HNGR)
SGRY vs HNGR Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas HNGR's P/E ratio is 19.71. In terms of profitability, SGRY's ROE is -0.05%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, SGRY is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check HNGR's competition here
New Frontier Health Corporation (NYSE: NFH)
SGRY vs NFH Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, NFH has a market cap of 0. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas NFH's P/E ratio is -19.75. In terms of profitability, SGRY's ROE is -0.05%, compared to NFH's ROE of -0.06%. Regarding short-term risk, SGRY is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check NFH's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
SGRY vs SLHGP Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, SGRY's ROE is -0.05%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, SGRY is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check SLHGP's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
SGRY vs SLHG Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas SLHG's P/E ratio is -1.48. In terms of profitability, SGRY's ROE is -0.05%, compared to SLHG's ROE of N/A. Regarding short-term risk, SGRY is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check SLHG's competition here
Almost Family Inc. (NASDAQ: AFAM)
SGRY vs AFAM Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas AFAM's P/E ratio is N/A. In terms of profitability, SGRY's ROE is -0.05%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, SGRY is less volatile compared to AFAM. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
SGRY vs TLMDW Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas TLMDW's P/E ratio is N/A. In terms of profitability, SGRY's ROE is -0.05%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, SGRY is less volatile compared to TLMDW. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check TLMDW's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
SGRY vs TLMD Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas TLMD's P/E ratio is -1.60. In terms of profitability, SGRY's ROE is -0.05%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, SGRY is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check TLMD's competition here
DocGo Inc. (NASDAQ: DCGOW)
SGRY vs DCGOW Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas DCGOW's P/E ratio is N/A. In terms of profitability, SGRY's ROE is -0.05%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, SGRY is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for SGRY.Check DCGOW's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
SGRY vs DVCR Comparison August 2026
Surgery Partners, Inc. (NASDAQ: SGRY) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SGRY stands at 2B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, SGRY is priced at $15.03 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SGRY currently has a P/E ratio of 38.54, whereas DVCR's P/E ratio is 28.34. In terms of profitability, SGRY's ROE is -0.05%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, SGRY is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for SGRY.Check DVCR's competition here